Dow Down 0.02% Nasdaq Up 0.07%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
413.00 Up 3.25(0.79%) 4:00PM EST
|After Hours : 413.00 0.00 (0.00%) 5:43PM EST
Prev Close:409.75
Open:416.00
Bid:409.50 x 100
Ask:415.00 x 100
1y Target Est:404.15
Beta:1.6
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:408.48 - 416.49
52wk Range:257.69 - 419.27
Volume:818,275
Avg Vol (3m):823,958
Market Cap:41.63B
P/E (ttm):141.20
EPS (ttm):2.93
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
REGNUp 0.79%41.63B
AMGNDown 1.18%123.41B
NVSUp 0.28%229.87B
RHHBYDown 0.37%252.84B

Key Statistics

Forward P/E (1 yr):35.09
P/S (ttm):15.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :9.97
Quarterly EPS Est (Dec-14) :2.75
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback